- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05993728
Virtual Body Project Groups Led by Peers Versus Clinicians (v-BP)
April 1, 2024 updated by: Line Wisting, Oslo University Hospital
Effectiveness of the Body Project to Prevent Eating Disorders in Young Females at Risk: a Randomized Controlled Trial
Eating disorders (EDs) are a group of illnesses associated with significant psychological and physiological consequences.
Overall, only 20% of individuals with EDs receive treatment and treatment is effective for only about 25-35% for those who receive care.
The development and implementation of effective prevention approaches for those at risk is therefore pivotal.
The Body Project is the most effective ED prevention program for at-risk females according to meta-analyses, but reach has been limited since delivery has traditionally been in-person.
Further research is warranted to examine cost-effective and easily accessible approaches to increase scalability and potential for broad implementation.
With this application, the investigators therefore propose to examine the effectiveness of the Body Project in young females, a high-risk group, with the following main novel aspects: i) virtually-delivered Body Project groups to maximize reach; ii) peer-led versus clinician-led virtually-delivered Body Project groups; iii) the inclusion of objective measures to assess engagement of intervention targets (i.e., mediator).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
441
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Line Wisting, PhD
- Phone Number: +4793495268
- Email: uxwili@ous-hf.no
Study Locations
-
-
-
Oslo, Norway
- Recruiting
- Oslo University Hospital
-
Contact:
- Line Wisting, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 16-25
- Female identifying
- Self-reported body image concerns
Exclusion Criteria:
- Ongoing eating disorder diagnosis requiring treatment or hospitalization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Clinician-led Body Project
Participants randomized to this condition will take part in virtual Body Project groups led by clinicians.
|
The Body Project prevention program is a body acceptance program to promote a healthy body image and prevent eating disorder onset.
|
Experimental: Peer-led Body Project
Participants randomized to this condition will take part in virtual Body Project groups led by peers.
|
The Body Project prevention program is a body acceptance program to promote a healthy body image and prevent eating disorder onset.
|
Active Comparator: Educational control
Participants randomized to the educational control group will receive educational videos on body image and eating disorders
|
Participants randomized to the educational control condition will receive videos addressing body image and eating disorders
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change over time in eating disorder symptoms
Time Frame: Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Assessed with the 28-item self-report Eating Disorder Examination Questionnaire (EDE-Q).
Responses range from 0-6, whith higher scores indicating more severe eating disorder psychopathology
|
Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Rate of eating disorder onset
Time Frame: Baseline/pretest, 1-year, and at 2-years
|
Assessed with the eating disorder diagnostic interview Eating Disorder Assessment-5 (EDA-5).
This is a semi-structured clinician-led diagnostic interview, based on the diagnostic criteria in the diagnostic manual DSM-5, and is efficient to determine eating disorder diagnostic status.
This outcome will be used to determine proportion of participants with an eating disorder diagnosis.
|
Baseline/pretest, 1-year, and at 2-years
|
Change over time in Body dissatisfaction
Time Frame: Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Assessed with the 10-item Body Dissatisfaction Scale (BDI; Berscheid et al., 2973) which assesses dissatisfaction with various body parts.
Each item is scored on a scale of 1 = extremely dissatisfied to 5 = extremely satisfied.
Lower scores indicate greater body dissatisfaction
|
Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Change over time in thin-ideal internalization
Time Frame: Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Assessed with the 8-item Ideal-Body Stereotype Scale-Revised (Stice et al., 2017) which measures pursuit of the thin ideal.
Each item is scored on a scale of 1 = strongly disagree to 5 = strongly agree.
Higher scores indicate greater belief in the thin-deal.
|
Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Negative affect
Time Frame: Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
20 negative items from the Positive and Negative Affect Schedule - Revised (PANAS-X) (Watson & Clark, 1992) to measure negative affect.
Higher scores indicate higher levels of negative affect.
Responses range from 1-5
|
Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change over time in appearance ideals and perceived pressures
Time Frame: Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Assessed with the Attitudes Towards Appearance Questionnaire (SATAQ-4R) (Schaefer et al., 2017).
A total of 31 items are included, and responses range from 1-5.
Higher scores indicate higher levels of internalization/pressures
|
Baseline/pretest, posttest right after intervention (an average of 8 weeks), and at follow-up after 6-months, 1-year, and 2-years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Line Wisting, PhD, Oslo University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
July 31, 2023
First Submitted That Met QC Criteria
August 8, 2023
First Posted (Actual)
August 15, 2023
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 609734
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Image
-
University of SheffieldCompletedBody Image Disturbance | Body Image | ShameUnited Kingdom
-
Trakya UniversityMedipol UniversityCompleted
-
Duke UniversityTerminatedImage, BodyUnited States
-
University of the West of EnglandUnilever R&D; UNICEF; Deakin University; Talk 2 U; Instituto Federal Sudeste de Minas...Completed
-
University of the West of EnglandTata Institute of Social Sciences; Lady Shri Ram College for WomenCompleted
-
Chapman UniversityOhio State UniversityUnknown
-
University College DublinIrish Research Council; Jigsaw, The National Centre for Youth Mental Health... and other collaboratorsRecruiting
-
University of the West of EnglandUniversity of Hawaii; Indonesia University; Unilever R&DCompletedBody ImageUnited Kingdom
-
University of the West of EnglandUnilever R&D; C+R research agencyCompleted
Clinical Trials on Body Project
-
Cornell CollegeNational Institute of Mental Health (NIMH)Completed
-
Ostfold University CollegeOslo University Hospital; Norwegian School of Sport SciencesCompletedAthletic Injuries | Eating Disorders | Adolescent - Emotional Problem | Body Dissatisfaction | Disordered EatingNorway
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Overweight | Body ImageUnited States
-
Oregon Research InstituteUniversity of Texas at Austin; Drexel UniversityCompletedObesity | Eating DisordersUnited States
-
University of Colorado, BoulderCompletedEating Disorders in AdolescenceUnited States
-
Oslo University HospitalThe Dam Foundation; Norwegian Diabetes AssociationTerminatedFeeding and Eating Disorders | Diabetes Mellitus, Type 1 | Body ImageNorway
-
Illinois Institute of TechnologyDePaul UniversityCompletedHealth BehaviorUnited States
-
University of CalgaryCompletedBody-dissatisfactionCanada
-
Oslo University HospitalJuvenile Diabetes Research Foundation; Stanford University; University of Minnesota and other collaboratorsRecruitingType 1 Diabetes | Eating DisordersUnited States, Norway, Netherlands
-
Stanford UniversityCompletedType 1 Diabetes | Eating DisordersUnited States